United States5d ago
Colossal Biosciences adds bluebuck to de-extinction portfolio, targets 2028 birth
Colossal Biosciences, the company working to revive woolly mammoths and dodos, announced the bluebuck as its sixth de-extinction target. CEO Ben Lamm says they aim for a birth around 2028.
Sources
1 verified
Location
—
Updated
Friday, 1 May 2026 at 23:38 UTC
No media · text-only dispatch